SEC

Watchdog Files SEC Complaint Against Natera Inc. for Misleading Investors

Today, Campaign for Accountability filed a complaint with the Securities and Exchange Commission requesting an investigation into Natera Inc., a clinical genetic testing company. Following New York Times reporting on the company’s prenatal tests, CfA alleges that Natera appears to have misled investors about the accuracy of its prenatal genetic tests and failed to disclose the investor risk associated with tests resulting in false positives.

Broad Coalition Urges McConnell to Drop Secret-Money Rider 

On September 26, 2016, 37 organizations signed an open letter to Senate Majority Leader Mitch McConnell, urging McConnell to reject any poison pill language in budget legislation that would prohibit the Securities and Exchange Commission from strengthening corporate disclosure laws by requiring transparency of secret political spending.

Get the latest news and actions

Sign up for updates